Literature DB >> 15357644

Introduction of NS5A mutations enables subgenomic HCV replicon derived from chimpanzee-infectious HC-J4 isolate to replicate efficiently in Huh-7 cells.

S Maekawa1, N Enomoto, N Sakamoto, M Kurosaki, E Ueda, T Kohashi, H Watanabe, C-H Chen, T Yamashiro, Y Tanabe, N Kanazawa, M Nakagawa, C Sato, M Watanabe.   

Abstract

Hepatitis C virus (HCV) subgenomic replicon has been reported to replicate efficiently and continuously in human hepatoma Huh-7 cells. To extend the previous results to other isolated HCV clones, we constructed another HCV replicon from HC-J4, one of chimpanzee-infectious HCV clones. An HCV replicon derived from HC-J4 (RpJ4) consists of HCV-5' untranslated region, neomycin phosphotransferase gene, the encephalomyocarditis virus internal ribosomal entry site, HCV nonstructural region, NS3 to NS5B, and HCV-3' untranslated region. The adaptive mutations known to be required for HCV-Con1 replicon were introduced in RpJ4 replicon, aa.(amino acids number according to HC-J4) 2197 serine to proline, deletion of serine at aa.2201, and aa.2204 serine to isoleucine (RpJ4-S2197P, RpJ4-S22001del, and RpJ4-S2204I). RpJ4/ISDR mutant and RpJ4-S2201del/ISDR mutant were also constructed by introducing six amino acid mutations into the interferon sensitivity determining region (ISDR). After transfection into Huh-7 cells and G418 selection, RpJ4 and RpJ4/ISDR mutants did not produce any colony. In contrast, G418-resistant cells were transduced efficiently by RpJ4-S2197P, RpJ4-S2204I, RpJ4-S2201del and RpJ4-S2201del/ISDR mutant, with the RpJ4-S2201del/ISDR mutant being most efficient. Hence the HCV replicon derived from HC-J4 can replicate efficiently following the introduction of adaptive mutations into the upstream region of ISDR. Moreover, additional introduction of mutations into ISDR further enhanced its replication. These findings demonstrate that the genetic structure of the NS5A domain is critical in HCV replications.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15357644     DOI: 10.1111/j.1365-2893.2004.00525.x

Source DB:  PubMed          Journal:  J Viral Hepat        ISSN: 1352-0504            Impact factor:   3.728


  8 in total

1.  Novel cell culture-adapted genotype 2a hepatitis C virus infectious clone.

Authors:  Tomoko Date; Takanobu Kato; Junko Kato; Hitoshi Takahashi; Kenichi Morikawa; Daisuke Akazawa; Asako Murayama; Keiko Tanaka-Kaneko; Tetsutaro Sata; Yasuhito Tanaka; Masashi Mizokami; Takaji Wakita
Journal:  J Virol       Date:  2012-07-11       Impact factor: 5.103

2.  Mutations in carboxy-terminal part of E2 including PKR/eIF2alpha phosphorylation homology domain and interferon sensitivity determining region of nonstructural 5A of hepatitis C virus 1b: their correlation with response to interferon monotherapy and viral load.

Authors:  Koji Ukai; Masatoshi Ishigami; Kentaro Yoshioka; Naoto Kawabe; Yoshiaki Katano; Kazuhiko Hayashi; Takashi Honda; Motoyoshi Yano; Hidemi Goto
Journal:  World J Gastroenterol       Date:  2006-06-21       Impact factor: 5.742

3.  Mutations in the interferon sensitivity determining region and virological response to combination therapy with pegylated-interferon alpha 2b plus ribavirin in patients with chronic hepatitis C-1b infection.

Authors:  Mina Nakagawa; Naoya Sakamoto; Mayumi Ueyama; Kaoru Mogushi; Satoshi Nagaie; Yasuhiro Itsui; Seishin Azuma; Sei Kakinuma; Hiroshi Tanaka; Nobuyuki Enomoto; Mamoru Watanabe
Journal:  J Gastroenterol       Date:  2010-01-30       Impact factor: 7.527

4.  Regulation of hepatitis C virus replication by interferon regulatory factor 1.

Authors:  Nobuhiko Kanazawa; Masayuki Kurosaki; Naoya Sakamoto; Nobuyuki Enomoto; Yasuhiro Itsui; Tsuyoshi Yamashiro; Yoko Tanabe; Shinya Maekawa; Mina Nakagawa; Cheng-Hsin Chen; Sei Kakinuma; Shigeru Oshima; Tetsuya Nakamura; Takanobu Kato; Takaji Wakita; Mamoru Watanabe
Journal:  J Virol       Date:  2004-09       Impact factor: 5.103

Review 5.  New hepatitis C virus drug discovery strategies and model systems.

Authors:  Snawar Hussain; Naina Barretto; Susan L Uprichard
Journal:  Expert Opin Drug Discov       Date:  2012-08-04       Impact factor: 6.098

6.  Replication of a hepatitis C virus replicon clone in mouse cells.

Authors:  Susan L Uprichard; Josan Chung; Francis V Chisari; Takaji Wakita
Journal:  Virol J       Date:  2006-10-28       Impact factor: 4.099

7.  Interferon sensitivity-determining region of hepatitis C virus influences virus production and interferon signaling.

Authors:  Ryuichi Sugiyama; Asako Murayama; Sayuri Nitta; Norie Yamada; Megumi Tasaka-Fujita; Takahiro Masaki; Hussein Hassan Aly; Masaaki Shiina; Akihide Ryo; Koji Ishii; Takaji Wakita; Takanobu Kato
Journal:  Oncotarget       Date:  2017-12-21

8.  Inhibition of hepatitis C virus infection and expression in vitro and in vivo by recombinant adenovirus expressing short hairpin RNA.

Authors:  Naoya Sakamoto; Yoko Tanabe; Takanori Yokota; Kenichi Satoh; Yuko Sekine-Osajima; Mina Nakagawa; Yasuhiro Itsui; Megumi Tasaka; Yuki Sakurai; Chen Cheng-Hsin; Masahiko Yano; Shogo Ohkoshi; Yutaka Aoyagi; Shinya Maekawa; Nobuyuki Enomoto; Michinori Kohara; Mamoru Watanabe
Journal:  J Gastroenterol Hepatol       Date:  2007-08-07       Impact factor: 4.029

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.